Search research articles
Contact Us
Filters
Showing results (611-620 of 712) with videos related to
Page
of 72
Sort By:
Genomics
|
October 15, 1996
Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-p25
A Grossman, H W Mittrücker, J Nicholl, et al.
Annals of Internal Medicine
|
November 1, 1979
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial
J P Glazer, H M Friedman, R A Grossman, et al.
Neuro-Oncology
|
July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
Myrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
European Radiology
|
July 9, 2004
Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome)
R K Lingam, S A Sohaib, A G Rockall, et al.
Neuro-Oncology
|
February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11
Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
Oncoimmunology
|
June 15, 2018
Systemic depletion of lymphocytes following focal radiation to the brain in a murine model
Anna F Piotrowski, Thomas R Nirschl, Esteban Velarde, et al.
Nucleic Acids Research
|
June 25, 1995
Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)
T Matsuyama, A Grossman, H W Mittrücker, et al.
Journal of Neuro-Oncology
|
March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Journal of Neuro-Oncology
|
December 3, 2015
The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain
Sadhana Jackson, Nicole M Anders, Antonella Mangraviti, et al.
Neuro-Oncology
|
September 29, 2011
Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma
L B Nabors, J G Supko, M Rosenfeld, et al.
Page
of 72
Search research articles
Search
Showing results (611-620 of 712) with videos related to
Sort By:
Page
of 72
Genomics
|
October 15, 1996
Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-p25
A Grossman, H W Mittrücker, J Nicholl, et al.
Annals of Internal Medicine
|
November 1, 1979
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial
J P Glazer, H M Friedman, R A Grossman, et al.
Neuro-Oncology
|
July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
Myrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
European Radiology
|
July 9, 2004
Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome)
R K Lingam, S A Sohaib, A G Rockall, et al.
Neuro-Oncology
|
February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11
Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
Oncoimmunology
|
June 15, 2018
Systemic depletion of lymphocytes following focal radiation to the brain in a murine model
Anna F Piotrowski, Thomas R Nirschl, Esteban Velarde, et al.
Nucleic Acids Research
|
June 25, 1995
Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)
T Matsuyama, A Grossman, H W Mittrücker, et al.
Journal of Neuro-Oncology
|
March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Journal of Neuro-Oncology
|
December 3, 2015
The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain
Sadhana Jackson, Nicole M Anders, Antonella Mangraviti, et al.
Neuro-Oncology
|
September 29, 2011
Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma
L B Nabors, J G Supko, M Rosenfeld, et al.
Page
of 72